Research summary ·
Apolipoprotein E Alleles Across the Spectrum of Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.
Machine-written explainer in our own words, checked against the source record · 12 Nov 2026. How it's made
What was studied
This review looked at APOE gene variants in frontotemporal lobar degeneration. It compared carrier status with healthy controls. It also compared it with people with Alzheimer's disease. Searches covered MEDLINE, Embase, CENTRAL and Google Scholar. The review included many studies. It pooled odds ratios for carrier status.
What they found
APOE4 was more common in frontotemporal dementia than in controls. Its odds ratio was 1.72. It was less common than in Alzheimer's disease. APOE2 was less common than in controls. It was more common than in Alzheimer's disease. APOE4 effects were strongest in the behavioral variant. In clinically confirmed PSP, no link was seen. APOE2 showed no link to PSP either.
What it means for patients
The authors say APOE alleles show distinct links across the FTLD spectrum. These links differ by disorder.
Why it is not certain yet
Data were too limited for other disorders. In confirmed PSP, lower APOE4 carriage missed the adjusted threshold. Evidence could not settle links for other disorders. This is the limit the abstract states.
Source
Apolipoprotein E Alleles Across the Spectrum of Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.
PubMed · PMID 42737648We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Frontotemporal dementia news